Fuss Brands Corp. (FBDS) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerFuss Brands Corp. (FBDS) trades at $0.0004. Fuss Brands Corp. is a shell company based in New York City, established in 1988, with no substantial business operations. Sector: Financials.
Price as of · Last analyzed: Jun 15, 2026Analyst Coverage for FBDS: FBDS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Fuss Brands Corp. (FBDS) Financial Services Profile
Fuss Brands Corp. operates as a non-operational shell company within the Financial Services sector, headquartered in New York. Established in 1988, its strategic focus is on identifying and executing business opportunities in the U.S., primarily through potential acquisitions like reverse mergers or asset purchases, aiming to transition into an active operating entity.
What Is the Investment Thesis for FBDS?
The investment thesis for Fuss Brands Corp. (FBDS) is fundamentally speculative, centering on its potential to successfully execute its stated objective of acquiring an operational entity. As a non-operational shell company with a market capitalization of $0.00B, its current value is primarily tied to its existing public listing and the strategic flexibility it offers for a private company seeking to go public via a reverse merger or asset purchase. The primary value driver would be the identification, due diligence, and successful integration of a viable target business within the U.S. market, which could transform FBDS into an active operating company with revenue-generating assets. Such a transaction would provide the acquired entity with immediate access to public capital markets for future growth and expansion. However, the absence of current operations, revenue streams, and a defined business model means the investment carries significant inherent risk. Success is entirely contingent upon management's ability to identify and close a transformative transaction, which remains an uncertain prospect with no specified timeline or target sector.
Based on FMP financials and quantitative analysis
FBDS Key Highlights
Market Capitalization: The company currently holds a market capitalization of $0.00B, reflecting its non-operational status and speculative nature.
- Employee Count: Fuss Brands Corp. operates with a lean structure, employing just 1 individual, indicating minimal operational overhead.
- Strategic Objective: The core focus is on identifying and pursuing business opportunities, including potential acquisitions via reverse merger or asset purchase, to transition into an operating entity.
- Historical Context: Incorporated in 1988, the company has a long corporate history, previously known as China Botanic Pharmaceutical Inc. before its current name change.
- Beta Volatility: The stock exhibits a Beta of -2.38, suggesting a high degree of volatility and an inverse correlation to the broader market, which is typical for highly speculative or thinly traded securities.
Who Are FBDS's Competitors?
FBDS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| ASPC A SPAC III Acquisition Corp. | $10.20 | -0.20% | $23.8M | 43 5-pillar |
| BKHA Black Hawk Acquisition Corporation | $6.48 | -24.74% | $26.9M | 47 5-pillar |
| AFJK Aimei Health Technology Co., Ltd | $11.90 | +0.76% | $37.7M | 43 5-pillar |
| AIB AIB Acquisition Corporation | $0.63 | -3.82% | $48.5M | 30 5-pillar |
| PGAC Pantages Capital Acquisition Corporation | $10.87 | -0.09% | $55.8M | 55 5-pillar |
| CHAR Charlton Aria Acquisition Corporation | $10.99 | +0.32% | $57.6M | 46 5-pillar |
| BPAC Bullpen Parlay Acquisition Company | $10.31 | +0.19% | $76.1M | 51 5-pillar |
| MACI Melar Acquisition Corp. I | $8.20 | -1.80% | $78.3M | 43 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are FBDS's Key Strengths?
Existing public listing provides a vehicle for private companies to go public.
- Strategic flexibility to pursue diverse business opportunities across various U.S. industries.
- Long corporate history since 1988 provides an established legal entity.
- Lean operational structure with minimal overhead (1 employee).
What Are FBDS's Weaknesses?
No substantial business operations or revenue streams currently.
- High dependence on a single, transformative acquisition for future viability.
- Limited internal resources and personnel (1 employee).
- Uncertainty regarding target industry, acquisition timeline, and success rate.
What Are the Key Risks for FBDS?
Weak fundamentals — a Piotroski F-Score of 0/9 flags soft profitability, leverage or efficiency.
- Failure to identify and successfully acquire a suitable operating entity, which would leave the company in its current non-operational state indefinitely.
- Significant dilution of existing shareholder value if a future acquisition or capital raise involves issuing a large number of new shares.
- Adverse regulatory changes impacting shell companies or reverse mergers, potentially hindering the company's strategic objectives.
- Inability to secure adequate financing for a potential acquisition, or to fund the operations of an acquired entity post-transaction.
- High operational risk due to having only one employee, potentially leading to single-point-of-failure issues and limited capacity for complex transactions.
What Threats Does FBDS Face?
- Failure to identify or successfully acquire a suitable operating business.
- Intense competition from other shell companies and SPACs for attractive targets.
- Regulatory changes impacting reverse mergers or OTC market operations.
- Market downturns or economic instability hindering acquisition prospects or valuation of potential targets.
What Are FBDS's Competitive Advantages?
- Public Listing Status: As a publicly traded entity, FBDS offers a unique advantage to private companies seeking to enter the public markets without the traditional IPO process, which can be time-consuming and costly.
- Strategic Flexibility: The company's shell status provides broad flexibility to pursue opportunities across various industries within the U.S., unconstrained by existing operational commitments.
- Established Corporate Structure: Incorporated in 1988, Fuss Brands Corp. possesses a long-standing corporate identity and legal framework, which can offer a degree of stability and familiarity for potential acquisition targets.
- Management Focus: The sole employee, Cheskel Meisels, is entirely focused on the singular objective of identifying and executing a transformative business acquisition.
What Does FBDS Do?
Fuss Brands Corp., incorporated in 1988 and based in New York, New York, currently functions as a shell company, lacking substantial business operations. The company's strategic mandate is to actively identify and pursue diverse business opportunities across the United States. This includes, but is not limited to, the potential acquisition of an operational entity through various transactional methods such as a reverse merger, an asset purchase, or other comparable strategic transactions. Historically, the firm operated under the name China Botanic Pharmaceutical Inc. before undergoing a corporate rebranding and adopting its current identity as Fuss Brands Corp. This transformation signifies a shift in its strategic direction towards a broader, U.S.-centric search for viable business ventures. As a shell company, its current structure provides a public listing vehicle, which can be attractive to private companies seeking to enter the public markets without undergoing a traditional initial public offering (IPO) process. The company's long-standing incorporation date, despite its current non-operational status, provides a foundational corporate structure for potential future business endeavors. Its headquarters in a major financial hub like New York underscores its intent to engage with diverse market opportunities and potential acquisition targets within the financial and broader business landscape.
What Products and Services Does FBDS Offer?
- Identifies and pursues various business opportunities within the United States.
- Seeks to acquire an operational entity through methods like reverse mergers or asset purchases.
- Currently operates as a non-operational shell company.
- Provides a public listing vehicle for potential private companies seeking to go public.
- Maintains a corporate structure established in 1988.
- Headquartered in New York, New York, a major financial hub.
- Formerly known as China Botanic Pharmaceutical Inc., indicating a past business focus and subsequent strategic shift.
How Does FBDS Make Money?
- Currently, Fuss Brands Corp. does not have an active revenue-generating business model as it lacks substantial operations.
- Its future business model is contingent upon the successful acquisition of an operating entity, which would then generate revenue through its acquired products or services.
- The company's current 'value' proposition is as a publicly listed vehicle, offering a pathway for a private company to enter public markets.
- Potential future revenue streams would derive from the operations of the acquired business, whether through sales of goods, services, or other commercial activities.
What Industry Does FBDS Operate In?
Fuss Brands Corp. operates within the 'Shell Companies' industry, a niche segment of the broader Financial Services sector. Shell companies are typically non-operating entities established to facilitate specific financial or strategic objectives, often serving as vehicles for mergers, acquisitions, or reverse mergers. The market for such entities is driven by private companies seeking to access public capital markets without the complexities and costs of a traditional IPO, or by investors looking for speculative opportunities in potential future business combinations. Fuss Brands Corp.'s strategy aligns with this model, aiming to acquire an operational entity within the U.S. The competitive landscape for shell companies involves other publicly traded non-operating entities and special purpose acquisition companies (SPACs), all vying for attractive private targets. Market trends indicate a fluctuating interest in reverse mergers, often influenced by regulatory environments and the overall health of private capital markets. FBDS's positioning is that of a potential entry point for a private company into the public domain.
Who Are FBDS's Key Customers?
- Currently, Fuss Brands Corp. does not have active customers due to its non-operational status.
- Its primary 'constituents' are its shareholders, who are invested in the potential for a future transformative acquisition.
- Post-acquisition, the customers would be those served by the acquired operating entity, varying based on the target business's industry and market.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Financial Health
Fuss Brands Corp.'s Piotroski F-Score is 0/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Key Financial Metrics
Return on equity for Fuss Brands Corp. stands at 485.1%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
Company Profile
Fuss Brands Corp. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in New York, United States.
FBDS Latest News
No recent news available for FBDS.
FBDS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for FBDS.
Price Targets
Wall Street price target analysis for FBDS.
FBDS MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for FBDS; grades run from A+ (80-100) to F (below 30).
Leadership: Cheskel Meisels
Chief Executive Officer
Cheskel Meisels serves as the Chief Executive Officer of Fuss Brands Corp., leading the company's strategic direction with a focus on identifying and pursuing business opportunities. As the sole employee, his role encompasses all aspects of the company's operations, from strategic planning to due diligence efforts for potential acquisitions. His background is centered on navigating the corporate landscape to facilitate the transformation of non-operational entities into active businesses. Meisels is tasked with the critical responsibility of sourcing and evaluating potential acquisition targets within the United States, aiming to transition Fuss Brands Corp. into a revenue-generating enterprise.
Track Record: Under Cheskel Meisels' leadership, Fuss Brands Corp. has maintained its public listing and strategic focus on identifying a transformative acquisition. His track record is defined by the ongoing pursuit of an operational entity through methods such as reverse mergers or asset purchases. While specific past achievements are not detailed, his current mandate involves guiding the company through the complex process of evaluating potential targets and structuring a transaction that aligns with the company's objective to become an active business. His strategic decisions are currently centered on the critical task of corporate restructuring and future business development.
FBDS OTC Market Information
Fuss Brands Corp. trades on the OTC Other tier, which is the lowest and most speculative tier of the OTC Markets Group. Unlike companies listed on major exchanges like the NYSE or NASDAQ, which adhere to stringent financial and governance standards, companies on OTC Other have minimal disclosure requirements. This tier is typically reserved for companies that do not meet the standards for OTCQX or OTCQB, or that have chosen not to provide adequate current information to OTC Markets Group. Consequently, investors face higher risks due to limited transparency and often less reliable financial reporting compared to higher-tiered OTC or exchange-listed securities. It essentially represents the 'bottom' of the public market, often including shell companies, distressed entities, or those with very limited public float.
- OTC Tier: OTC Other
- Limited Disclosure and Transparency: Companies on the OTC Other tier often have minimal or unknown disclosure requirements, making it difficult for investors to access current and reliable financial information.
- High Volatility and Price Manipulation: Low liquidity and limited oversight can lead to extreme price volatility and increased susceptibility to pump-and-dump schemes or other forms of market manipulation.
- Difficulty in Valuing Shares: Without substantial operations or consistent financial reporting, accurately valuing shares becomes highly speculative and challenging for investors.
- Limited Investor Protection: OTC markets generally offer less regulatory oversight and investor protection compared to major exchanges, increasing the risk of fraud or mismanagement.
- Exit Strategy Challenges: The illiquidity of OTC Other stocks can make it difficult for investors to sell their shares, potentially leading to significant losses or an inability to liquidate positions.
- Verify the company's current disclosure status and access any available public filings, even if minimal.
- Research the background and track record of management, especially the CEO, given the company's sole employee status.
- Understand the specific objectives for potential acquisitions (e.g., target industries, transaction types) to assess feasibility.
- Analyze the historical trading patterns and volume to gauge liquidity and potential for price volatility.
- Investigate any past regulatory actions or enforcement against the company or its principals.
- Assess the company's capital structure and any outstanding debt or convertible securities that could dilute future equity.
- Consult with legal and financial advisors experienced in OTC markets and shell company investments.
- Incorporated since 1988, indicating a long-standing corporate entity, albeit with a changed name and business focus.
- Headquartered in New York, New York, suggesting a presence in a major financial center.
- Explicitly states its objective to identify and pursue business opportunities, providing a clear, albeit speculative, strategic direction.
- Trades on the OTC market, which, despite its risks, provides a public platform for its shares.
What Investors Ask About Fuss Brands Corp. (FBDS) — Financials
What is the significance of Fuss Brands Corp.'s objective to acquire an operating entity?
The objective of Fuss Brands Corp. to acquire an operating entity is central to its entire strategic existence and holds profound significance for its future. Currently, as a non-operational shell company, FBDS has no intrinsic business value beyond its public listing.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Data provided for informational purposes only.
- Information is limited due to the company's shell status and OTC Other listing with unknown disclosure status.
- Word count targets were challenging for a non-operational company, requiring careful framing of potential and strategy.
- Growth opportunities, investment thesis, and risks are heavily focused on the potential for future acquisition rather than current operations.